Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck & Co. research leads to new fibrinogen receptor antagonist prodrugs

March 24, 1998

Lilly describes PAI-1-inhibitory benzothiophenes with cardioprotective effects

March 24, 1998

Beneficial effects of warfarin in patients with cardiac disorders

March 24, 1998

Merck & Co. reveals new prodrugs of fibrinogen receptor antagonists

March 23, 1998

Antiplatelet agents reported by researchers at Nippon Steel

March 20, 1998

Modified factor VII interrupts the coagulation cascade

March 18, 1998

Novartis describes new thrombin inhibitors

March 17, 1998

Centocor completes acquisition of reteplase

March 16, 1998

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Treatment of acute coronary syndromes by thrombin inhibition

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.